We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Formodual - nowa opcja terapeutyczna w leczeniu astmy i przewlekłej obturacyjnej choroby płuc w odpłatności ryczałtowej. Czy cena terapii może wpływać na przestrzeganie zaleceń terapeutycznych?
- Authors
Seweryn, Przemysław; Emeryk, Andrzej; Kupczyk, Maciej; Gawlik, Radosław; Dębowski, Tomasz; Sztaba, Grzegorz; Pawliczak, Rafał
- Abstract
The out-of-pocket cost of asthma and chronic obturative pulmonary disease therapy might be a limiting factor of the therapy for many patients in Poland. Does the out-of-pocket copayment influence the therapy choice, specifically where the treatment is reimbursed? Do the therapy cost paid by the patient have any influence on treatment compliance? Will the introduction of the generic medication identical to the innovative drug, but available at lower cost change the therapy adherence? In this review we are trying to answer the aforementioned questions.
- Subjects
POLAND; DRUG therapy for asthma; HEALTH services accessibility; MEDICAL care costs; PHARMACEUTICAL services insurance; HEALTH insurance reimbursement; PATIENTS' attitudes; TREATMENT effectiveness; OBSTRUCTIVE lung diseases; COST analysis; DRUGS; GENERIC drugs; PATIENT compliance; INSURANCE
- Publication
Polish Journal of Allergology / Alergologia Polska, 2023, Vol 10, Issue 3, p198
- ISSN
2353-3854
- Publication type
Article
- DOI
10.5114/pja.2023.131710